- Home
- MAIA vs GIFT Comparison
MAIA vs GIFT Comparison
Compare MAIA & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- GIFT
- Stock Information
- Founded
- MAIA 2018
- GIFT 1999
- Country
- MAIA United States
- GIFT United States
- Employees
- MAIA N/A
- GIFT N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- GIFT Catalog/Specialty Distribution
- Sector
- MAIA Health Care
- GIFT Consumer Discretionary
- Exchange
- MAIA Nasdaq
- GIFT Nasdaq
- Market Cap
- MAIA 46.7M
- GIFT 53.3M
- IPO Year
- MAIA 2022
- GIFT N/A
- Fundamental
- Price
- MAIA $1.95
- GIFT $1.69
- Analyst Decision
- MAIA
- GIFT Strong Buy
- Analyst Count
- MAIA 0
- GIFT 1
- Target Price
- MAIA N/A
- GIFT $4.00
- AVG Volume (30 Days)
- MAIA 283.6K
- GIFT 63.1K
- Earning Date
- MAIA 05-09-2025
- GIFT 05-13-2025
- Dividend Yield
- MAIA N/A
- GIFT N/A
- EPS Growth
- MAIA N/A
- GIFT N/A
- EPS
- MAIA N/A
- GIFT N/A
- Revenue
- MAIA N/A
- GIFT $89,689,155.00
- Revenue This Year
- MAIA N/A
- GIFT $12.22
- Revenue Next Year
- MAIA N/A
- GIFT N/A
- P/E Ratio
- MAIA N/A
- GIFT N/A
- Revenue Growth
- MAIA N/A
- GIFT 6.13
- 52 Week Low
- MAIA $1.40
- GIFT $0.50
- 52 Week High
- MAIA $4.31
- GIFT $4.27
- Technical
- Relative Strength Index (RSI)
- MAIA 57.09
- GIFT N/A
- Support Level
- MAIA $1.71
- GIFT N/A
- Resistance Level
- MAIA $1.81
- GIFT N/A
- Average True Range (ATR)
- MAIA 0.09
- GIFT 0.00
- MACD
- MAIA 0.00
- GIFT 0.00
- Stochastic Oscillator
- MAIA 70.59
- GIFT 0.00
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.